Ligand Induced Conformational Changes of the Human Serotonin Transporter Revealed by Molecular Dynamics Simulations

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Koldsø, Heidi ^a,b,c   Autzen, Henriette Elisabeth ^b   Grouleff, Julie ^b   Schiøtt, Birgit ^a,b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; GLUTAMIC ACID; GLYCINE; NORIBOGAINE; SEROTONIN; SEROTONIN TRANSPORTER;

ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; MOLECULAR DYNAMICS; MOLECULAR MODEL; MOLECULAR STABILITY; PROTEIN CONFORMATION;

COCAINE; HUMANS; IBOGAINE; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; PROTEIN CONFORMATION; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

AQUIFEX; BACTERIA (MICROORGANISMS);

EID: 84878940205     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063635     Document Type: Article

References (75)

1. Nelson PJ, Rudnick G, (1979) Coupling between platelet 5-hydroxytrypthamine and potassium transport. J Biol Chem 254: 10084-10089.
2. Jardetzky O, (1966) Simple allosteric model for membrane pumps. Nature 211: 969-970.
3. Forrest LR, Zhang Y, Jacobs MT, Gesmonde J, Xie L, et al. (2008) Mechanism for alternating access in neurotransmitter transporters. Proc Natl Acad Sci U S A 105: 10338-10343.
4. Rudnick G, Clark J, (1993) From synapse to vesicle: The reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1144: 249-263.
5. Yamashita A, Singh SK, Kawate T, Jin Y, Gouaux E, (2005) Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters. Nature 437: 215-223.
6. Beuming T, Shi L, Javitch JA, Weinstein H, (2006) A comprehensive structure-based alignment of prokaryotic and eukaryotic Neurotransmitter/Na+ Symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function. Mol Pharmacol 70: 1630-1642.
7. Koldsø H, Noer P, Grouleff J, Autzen HE, Sinning S, et al. (2011) Unbiased simulations reveal the inward-facing conformation of the human serotonin transporter and Na+ Ion release. PLoS Comput Biol 7(10): e1002246 doi:10.1371/journal.pcbi.1002246.
8. Koldsø H, Christiansen AB, Sinning S, Schiøtt B, (2013) Comparative modelling of the human monoamine transporters - similarities in substrate binding. ACS Chem Neurosci 4: 295-309.
9. Koldsø H, Severinsen K, Tran TT, Celik L, Jensen HH, et al. (2010) The two enantiomers of citalopram bind to the human serotonin transporter in reversed orientations. J Am Chem Soc 132: 1311-1322.
10. Sinning S, Musgaard M, Jensen M, Severinsen K, Celik L, et al. (2010) Binding and orientation of tricyclic antidepressants within the central substrate site of the human serotonin transporter. J Biol Chem 285: 8363-8374.
11. Severinsen K, Kraft JF, Koldsø H, Vinberg KA, Wiborg O, et al. (2012) Probing 1-phenyl-piperazine binding to monoamine transportes. ACS Chem Neurosci 3: 693-705.
12. Celik L, Sinning S, Severinsen K, Hansen C, Møller M, et al. (2008) Binding of serotonin to the human serotonin transporter. Molecular modeling and experimental validation. J Am Chem Soc 130: 3853-3865.
13. Beuming T, Kniazeff J, Bergmann ML, Shi L, Gracia L, et al. (2008) The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat Neurosci 11: 780-789.
14. Andersen J, Taboureau O, Hansen KB, Olsen L, Egebjerg J, et al. (2009) Location of the antidepressant binding site in the serotonin transporter: Importance of Ser-438 in the recognition of citalopram and tricyclic antidepressants. J Biol Chem 284: 10276-10284.
15. Andersen J, Olsen L, Hansen KB, Taboureau O, Jørgensen FS, et al. (2010) Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter. J Biol Chem 285: 2051-2063.
16. Indarte M, Madura J, Surratt C, (2008) Dopamine transporter comparative molecular modeling and binding site prediction using the LeuTAa leucine transporter as a template. Proteins 70: 1033-1046.
17. Jørgensen AM, Tagmose L, Jørgensen AMM, Bøgesø KP, Peters GH, (2007) Molecular dynamics simulations of Na+/Cl--dependent neurotransmitter transporters in a membrane-aqueous system. ChemMedChem 2: 827-840.
18. Jørgensen AM, Tagmose L, Jørgensen AMM, Topiol S, Sabio M, et al. (2007) Homology modeling of the serotonin transporter: Insights into the primary escitalopram-binding site. ChemMedChem 2: 815-826.
19. Quick M, Winther AL, Shi L, Nissen P, Weinstein H, et al. (2009) Binding of an octylglucoside detergent molecule in the second substrate (S2) site of LeuT establishes an inhibitor-bound conformation. Proc Natl Acad Sci U S A 106: 5563-5568.
20. Zhou Z, Zhen J, Karpowich NK, Law CJ, Reith MEA, et al. (2009) Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures. Nat Struct Mol Biol 16: 652-658.
21. Zhou Z, Zhen J, Karpowich NK, Goetz RM, Law CJ, et al. (2007) LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake. Science 317: 1390-1393.
22. Singh SK, Piscitelli CL, Yamashita A, Gouaux E, (2008) A competitive inhibitor traps LeuT in an open-to-out conformation. Science 322: 1655-1661.
23. Singh SK, Yamashita A, Gouaux E, (2007) Antidepressant binding site in a bacterial homologue of neurotransmitter transporters. Nature 448: 952-956.
24. Kroncke BM, Horanyi PS, Columbus L, (2010) Structural origins of nitroxide side chain dynamics on membrane protein α-helical sites. Biochemistry 49: 10045-10060.
25. Krishnamurthy H, Gouaux E, (2012) X-ray structures of LeuT in substrate-free outward-open and apo inward-open states. Nature 481: 469-474.
26. Nnadi CU, Mimiko OA, McCurtis HL. Cadet JL, (2005) Neuropsychiatric effects of cocaine use disorders. J Natl Med Assoc 97: 1504-1515.
27. Sofuoglu M, Kosten TR, (2006) Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opin Emerging Drugs 11: 91-98.
28. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ, (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223.
29. Bisgaard H, Larsen MA, Mazier S, Beuming T, Newman AH, et al. (2011) The binding sites for benztropines and dopamine in the dopamine transporter overlap. Neuropharmacology 60: 182-190.
30. Popik P, Layer RT, Skolnick P, (1995) 100 years of ibogaine: Neurochemical and pharmacological actions of a putative anti-addictive drug. Pharmacol Rev 47: 235-253.
31. Alper KR, Lotsof HS, Frenken GMN, Luciano DJ, Bastiaans J, (1999) Treatment of acute opioid withdrawal with ibogaine. Am J Addict 8: 234-242.
32. Sheppard SG, (1994) A preliminary investigation of ibogaine: Case reports and recommendations for further study. J Subst Abuse Treat 11: 379-385.
33. Mash DC, Kovera CA, Pablo J, Tyndale R, Ervin FR, et al. (2001) Ibogaine in the treatment of heroin withdrawal. Alkaloids Chem Biol 56: 155-171.
34. Jacobs MT, Zhang Y, Campbell SD, Rudnick G, (2007) Ibogaine, a noncompetitive inhibitor of serotonin transport, acts by stabilizing the cytoplasm-facing state of the transporter. J Biol Chem 282: 29441-29447.
35. Bulling S, Schicker K, Zhang Y, Steinkellner T, Stockner T, et al. (2012) The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters. J Biol Chem 287: 18524-18534.
36. Mash DC, Staley JK, Baumann MH, Rothman RB, Lee Hearn W, (1995) Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin. Life Sci 57: PL45-PL50.
37. Martens PF, Autzen HE, Koldsø H, Nami F, Jensen HH,et al. Orientation of the anti-addiction drug ibogaine within the central substrate site of the human serotonin transporter. In Preparation.
38. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, et al. (2007) Comparative protein structure modeling using MODELLER. Curr Protoc Protein Sci doi: 10.1002/0471140864.ps0209s50.
39. Sali A, Blundell TL, (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234: 779-815.
40. Gabe EJ, Barnes WH, (1962) The crystal and molecular structure of l-cocaine hydrochloride. Acta Cryst 16: 796-801.
41. Maestro, version 9.1 (2010) Schrödinger, LLC, New York, NY.
42. Epik, version 2.1 (2010) Schrödinger, LLC, New York, NY.
43. Shelley JC, Cholleti A, Frye LL, Greenwood JR, Timlin MR, et al. (2007) Epik: A software program for pKa prediction and protonation state generation for drug-like molecules. J Comp Aided Mol Des 21: 681-691.
44. Kolossváry I, Guida WC, (1996) Low mode search. an efficient, automated computational method for conformational analysis: Application to cyclic and acyclic alkanes and cyclic peptides. J Am Chem Soc 118: 5011-5019.
45. MacroModel, version 9.8 (2010) Schrödinger, LLC, New York, NY.
46. Banks FL, Beard HS, Yixiang C, Cho AR, Damm W, et al. (2005) Integrated modeling program, applied chemical theory (IMPACT). J Comput Chem 26: 1752-1780.
47. Schrödinger Suite 2010 Induced Fit Docking protocol. (2010) Glide version 5.6, Schrödinger, LLC, New York, NY, Prime version 2.2, Schrödinger, LLC, New York, NY.
48. Sherman W, Day T, Jacobson MP, Friesner RA, Farid R, (2006) Novel procedure for modeling ligand/receptor induced fit effects. J Med Chem 49: 534-553.
49. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, et al. (2004) Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy. J Med Chem 47: 1739-1749.
50. Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, et al. (2006) Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49: 6177-6196.
51. Schrödinger Suite 2010 Protein Preparation Wizard. (2010) Epik version 2.1, Schrödinger LLC, New York, NY, Impact version 5.6, Schrödinger, LLC, New York, NY, 2010, Prime version 2.2, Schrödinger, LLC, New York, NY.
52. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, et al. (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26: 1781-1802.
53. Jorgensen WL, Tirado-Rives J, (1988) The OPLS potential functions for proteins - energyminimizations for crystals of cyclic-peptides and crambin. J Am Chem Soc 110: 1666-1671.
54. Kaminski GA, Friesner RA, Tirado-Rives J, Jorgensen WL, (2001) Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. J Phys Chem B 105: 6474-6487.
55. Impact, version 5.6 (2005) Schrödinger, LLC, New York, NY.
56. MacKerell AD, Bashford D, Bellott M, Dunbrack RL, Evanseck JD, et al. (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102: 3586-3616.
57. Celik L, Schiøtt B, Tajkhorshid E, (2008) Substrate binding and formation of an occluded state in the leucine transporter. Biophys J 94: 1600-1612.
58. Shaikh SA, Tajkhorshid E, (2010) Modeling and dynamics of the inward-facing state of a Na+/Cl- dependent neurotransmitter transporter homologue. PLoS Comput Biol 6: e1000905 doi: 10.1371/journal.pcbi.1000905.
59. Fjorback AW, Pla P, Müller HK, Wiborg O, Saudou F, et al. (2009) Serotonin transporter oligomerization documented in RN46A cells and neurons by sensitized acceptor emission FRET and fluorescence lifetime imaging microscopy. Biochem Biophys Res Commun 380: 724-728.
60. Sitte HH, Farhan H, Javitch JA, (2004) Sodium-dependent neurotransmitter transporters: Oligomerization as a determinant of transporter function and trafficking. Mol Interv 4: 38-47.
61. Humphrey W, Dalke A, Schulten K, (1996) VMD: Visual molecular dynamics. J Mol Graph 14: 33-38.
62. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML, (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79: 926-935.
63. Martyna GJ, Tobias DJ, Klein ML, (1994) Constant pressure molecular dynamics algorithms. J Chem Phys 101: 4177-4189.
64. Feller SE, Zhang Y, Pastor RW, Brooks BR, (1995) Constant pressure molecular dynamics simulation: The langevin piston method. J Chem Phys 103: 4613-4621.
65. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, et al. (1995) A smooth particle mesh ewald method. J Chem Phys 103: 8577-8593.
66. Kristensen AS, Andersen J, Jørgensen TN, Sørensen L, Eriksen J, et al. (2011) SLC6 neurotransmitter transporters: Structure, function, and regulation. Pharmacol Rev 63: 585-640.
67. Aittoniemi J, de Wet H, Ashcroft FM, Sansom MSP, (2010) Asymmetric switching in a homodimeric ABC transporter: A simulation study. PLoS Comput Biol 6: e1000762 doi: 10.1371/journal.pcbi.1000762.
68. Baumann MH, Pablo J, Ali SF, Rothman RB, Mash DC, (2001) Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine. Alkaloids Chem Biol 56: 76-113.
69. Claxton DP, Quick M, Shi L, de Carvalho FD, Weinstein H, et al. (2010) Ion/substrate-dependent conformational dynamics of a bacterial homolog of Neurotransmitter:Sodium Symporters. Nat Struct Mol Biol 17: 822-829.
70. Zhang Y, Rudnick G, (2006) The cytoplasmic substrate permeation pathway of serotonin transporter. J Biol Chem 281: 36213-36220.
71. Korkhov VM, Holy M, Freissmuth M, Sitte HH, (2006) The conserved glutamate (Glu136) in transmembrane domain 2 of the serotonin transporter is required for the conformational switch in the transport cycle. J Biol Chem 281: 13439-13448.
72. Zhao C, Noskov SY, (2011) The role of local hydration and hydrogen-bonding dynamics in ion and solute release from ion-coupled secondary transporters. Biochemistry 50: 1848-1856.
73. Shi L, Quick M, Zhao Y, Weinstein H, Javitch JA, (2008) The mechanism of a Neurotransmitter:Sodium Symporter - Inward release of Na+ and substrate is triggered by substrate in a second binding site. Mol Cell 30: 667-677.
74. Shan J, Javitch JA, Shi L, Weinstein H, (2011) The substrate-driven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter. PLoS ONE 6: e16350 doi: 10.1371/journal.pone.0016350.
75. Plenge P, Shi L, Beuming T, Te J, Newman AH, et al. (2012) Steric hindrance mutagenesis in the conserved extracellular vestibule impedes allosteric binding of antidepressants to the serotonin transporter. J Biol Chem 287: 39316-39326.